Affordable Access

deepdyve-link
Publisher Website

Geographic disparities in access to scalp cooling for the prevention of chemotherapy-induced alopecia in the United States.

Authors
  • Singer, Sean1
  • Tkachenko, Elizabeth1
  • Sharma, Priyank2
  • Nelson, Caroline3
  • Mostaghimi, Arash2
  • LeBoeuf, Nicole R4
  • 1 Department of Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • 2 Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
  • 3 Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • 4 Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts; Center for Cutaneous Oncology, Department of Dermatology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts. Electronic address: [email protected]
Type
Published Article
Journal
Journal of the American Academy of Dermatology
Publication Date
Nov 01, 2021
Volume
85
Issue
5
Pages
1248–1252
Identifiers
DOI: 10.1016/j.jaad.2020.06.073
PMID: 32610170
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Chemotherapy-induced alopecia is psychologically challenging for patients undergoing cancer treatment, and scalp cooling has been shown to prevent or decrease the hair loss. To evaluate whether access to scalp cooling varies by geographic area in the United States. Cancer treatment centers offering scalp cooling were identified using data from the Rapunzel Project. Medicare claims data were queried to evaluate the number of chemotherapy infusions occurring in each zip code in the United States. Geographic distribution of chemotherapy infusions and scalp cooling centers was determined using ArcGIS software. The average distance from the geographic center of all 5-digit zip codes in which chemotherapy infusions occur to the nearest scalp cooling center was calculated in miles. There are 366 chemotherapy infusion centers in the United States that offer scalp cooling. Overall, 43.9% of Medicare-billed chemotherapy infusions in the United States occur in zip codes less than 12.5 miles from a scalp cooling center, 24.8% occur between 12.5 and 49.9 miles away, and 31.3% occur more than 50 miles away. Our results are only generalizable to patients seen at Medicare-accepting institutions in the United States. Geographic disparities affect which patients can access scalp cooling therapy, and implementation in suburban and rural areas would increase access for patients who wish to preserve their hair while undergoing chemotherapy. Copyright © 2020. Published by Elsevier Inc.

Report this publication

Statistics

Seen <100 times